PTPI: Petros Pharmaceuticals, Inc. Common Stock Company Profile & Statistics

About

Petros Pharmaceuticals Inc. is a men's health company. It engages in identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders. Petros Pharmaceuticals Inc., formerly known as Neurotrope Inc., is based in NEW YORK.

Info & Links

CEO

Joshua N. Silverman

Headquarters

1185 AVENUE OF THE AMERICAS, 3RD FLOOR
NEW YORK, NY 10036, UNITED STATES

Auditor

Marcum LLP

Share holders

312

Employees

Petros Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

1.51M

Enterprise Value

5.05M

Enterprise Value/EBITDA(ttm)

-0.43

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

0.43

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

74.56%

Operating Margin(ttm)

Profit Margin(ttm)

-647.62%

Return on Equity(ttm)

-78.22%

Return on Invested Capital(ttm)

78.44%

Return on Assets(ttm)

-23.50%

Income Statement

Revenue(ttm)

5.11M

Revenue Per Share(ttm)

0.10

Gross Profit(ttm)

3.90M

EBITDA(ttm)³

-11.77M

Net Income Available to Common(ttm)

-26.80M

Diluted EPS(ttm)

-4.76

Share Statistics

Beta (5Y Monthly)

1.84

52-Week Change

-92.42%

S&P 500 52-Week Change

6.00%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

53.52M

Dividend Yield

0.00%

Float⁴

9.93M

% Held by Insiders

12.25%

% Held by Institutions

12.34%

Balance Sheet

Total Cash(mrq)

3.71M

Total Cash Per Share(mrq)

0.07

Total Debt(mrq)

7.25M

Total Debt/Equity(mrq)

-97.07%

Current Ratio(mrq)

0.40%

Quick Ratio(mrq)

0.74%

Book Value Per Share(mrq)

-0.71

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.32

Free Cash Flow(ytd)

-2.63M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

PTPI

Petros Pharmaceuticals, Inc. Common Stock

Petros Pharmaceuticals, Inc. Common Stock Profile